JP2025506419A5 - - Google Patents
Info
- Publication number
- JP2025506419A5 JP2025506419A5 JP2024546193A JP2024546193A JP2025506419A5 JP 2025506419 A5 JP2025506419 A5 JP 2025506419A5 JP 2024546193 A JP2024546193 A JP 2024546193A JP 2024546193 A JP2024546193 A JP 2024546193A JP 2025506419 A5 JP2025506419 A5 JP 2025506419A5
- Authority
- JP
- Japan
- Prior art keywords
- gjb2
- polynucleotide
- nucleic acid
- acid vector
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263306941P | 2022-02-04 | 2022-02-04 | |
| US202263306928P | 2022-02-04 | 2022-02-04 | |
| US63/306,941 | 2022-02-04 | ||
| US63/306,928 | 2022-02-04 | ||
| PCT/US2023/061953 WO2023150689A2 (en) | 2022-02-04 | 2023-02-03 | Gjb2 regulatory elements and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506419A JP2025506419A (ja) | 2025-03-11 |
| JP2025506419A5 true JP2025506419A5 (https=) | 2026-02-04 |
Family
ID=87552983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546193A Pending JP2025506419A (ja) | 2022-02-04 | 2023-02-03 | Ｇｊｂ２調節エレメント及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250127928A1 (https=) |
| EP (1) | EP4473005A4 (https=) |
| JP (1) | JP2025506419A (https=) |
| KR (1) | KR20240156606A (https=) |
| AU (1) | AU2023214481A1 (https=) |
| CA (1) | CA3250345A1 (https=) |
| CL (1) | CL2024002306A1 (https=) |
| CO (1) | CO2024012057A2 (https=) |
| IL (1) | IL314705A (https=) |
| MX (1) | MX2024009520A (https=) |
| WO (1) | WO2023150689A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260027327A1 (en) | 2024-07-26 | 2026-01-29 | Regeneron Pharmaceuticals, Inc. | Otic drug delivery system and methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220130093A (ko) * | 2019-10-30 | 2022-09-26 | 데시벨 테라퓨틱스, 인크. | 오토펄린 듀얼 벡터 시스템을 사용한 감각신경성 난청을 치료하기 위한 조성물 및 방법 |
| WO2021231808A2 (en) * | 2020-05-13 | 2021-11-18 | Akouos, Inc. | Compositions and methods for treating gjb2-associated hearing loss |
-
2023
- 2023-02-03 MX MX2024009520A patent/MX2024009520A/es unknown
- 2023-02-03 WO PCT/US2023/061953 patent/WO2023150689A2/en not_active Ceased
- 2023-02-03 JP JP2024546193A patent/JP2025506419A/ja active Pending
- 2023-02-03 AU AU2023214481A patent/AU2023214481A1/en active Pending
- 2023-02-03 EP EP23750443.6A patent/EP4473005A4/en active Pending
- 2023-02-03 KR KR1020247029441A patent/KR20240156606A/ko active Pending
- 2023-02-03 IL IL314705A patent/IL314705A/en unknown
- 2023-02-03 US US18/835,452 patent/US20250127928A1/en active Pending
- 2023-02-03 CA CA3250345A patent/CA3250345A1/en active Pending
-
2024
- 2024-07-31 CL CL2024002306A patent/CL2024002306A1/es unknown
- 2024-09-04 CO CONC2024/0012057A patent/CO2024012057A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11834649B2 (en) | CRISPR/CAS-related methods and compositions for treating herpes simplex virus | |
| EP3353298B1 (en) | Allele selective gene editing and uses thereof | |
| EP1544297B1 (en) | Medicament for treatment of Duchenne muscular dystrophy | |
| CN107406852B (zh) | 用于莱伯氏先天性黑蒙的寡核苷酸疗法 | |
| JP2021518102A5 (https=) | ||
| JP2022546608A5 (https=) | ||
| JP2023510352A5 (https=) | ||
| EP3540061A1 (en) | Crispr/cas-related methods and compositions for treating primary open angle glaucoma | |
| US20230032846A1 (en) | Systems and methods for lipid nanoparticle delivery of gene editing machinery | |
| JP2000512853A (ja) | 非天然ヌクレオチドを有するキメラ突然変異性ベクター | |
| JP2017536338A5 (https=) | ||
| JP2018538288A5 (https=) | ||
| JP2023512758A5 (https=) | ||
| JP2024511131A5 (https=) | ||
| WO2019224864A1 (ja) | Ｓｃｎ１ａ遺伝子の発現増強法とそれによるドラベ症候群の治療法 | |
| JP2024538076A5 (https=) | ||
| JP2025506419A5 (https=) | ||
| CN117363594A (zh) | 一种可控制的RNA m6A去甲基化编辑系统及其应用 | |
| KR20250053925A (ko) | CRISPR-Cas13 시스템 및 이의 용도 | |
| KR20230134097A (ko) | Nhej 복구 경로 조절을 통해 핵산 세그먼트의 결실 효율을 증가시키기 위한 조성물 및 방법 | |
| JP2025502346A5 (https=) | ||
| KR20240040112A (ko) | 방법 | |
| JP2024529108A5 (https=) | ||
| JP2024521750A5 (https=) | ||
| JP2022548320A (ja) | アポリポタンパク質ｂ（ａｐｏｂ）遺伝子発現をモジュレートするための組成物および方法 |